70 Publikationen
-
2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2993910Comparison of established and preliminarily proposed ASAS MRI working group cut-offs for inflammatory MRI lesions in the sacroiliac joints in radiographic and non-radiographic axial spondyloarthritisPUB | DOI | WoS | PubMed | Europe PMC
Baraliakos X, Machado PM, Bauer L, Hoepken B, Kim M, Kumke T, Tham R, Rudwaleit M (2024)
RMD Open 10(3): e003886. -
2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993104Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 TrialsPUB | DOI | WoS
Bessette L, Rudwaleit M, Brown M, van Gaalen F, Haroon N, Gensler L, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, et al. (2024)
Journal of Rheumatology 51(Suppl. 1): 67-68. -
2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2992549Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritisPUB | DOI | WoS | PubMed | Europe PMC
Rudwaleit M, Marzo-Ortega H, Navarro-Compán V, Tham R, Kumke T, Bauer L, de Peyrecave N, Kim M, van den Bosch F (2024)
RMD Open 10(3): e004369. -
2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2990625Reporting Sacroiliac Joint Imaging Performed for Known or Suspected Axial Spondyloarthritis: Assessment of SpondyloArthritis International Society RecommendationsPUB | DOI | WoS | PubMed | Europe PMC
Diekhoff T, Eshed I, Giraudo C, Haibel H, Hermann KGA, de Hooge M, Jans L, Jurik AG, Lambert RG, Machado P, Mallinson M, et al. (2024)
Radiology 311(3): e231786. -
2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2991327Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trialsPUB | DOI | WoS | PubMed | Europe PMC
Brown MA, Rudwaleit M, van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, White K, et al. (2024)
Annals of the Rheumatic Diseases. -
2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2990777Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studiesPUB | DOI | WoS | PubMed | Europe PMC
Dubreuil M, Navarro-Compán V, Boonen A, Gaffney K, Gensler LS, de la Loge C, Vaux T, Fleurinck C, Massow U, Taieb V, Morup MF, et al. (2024)
RMD Open 10(2): e004202. -
2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2990773Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2PUB | DOI | WoS
Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, de Peyrecave N, Vaux T, Marzo-Ortega H, Navarro-Compán V (2024)
Rheumatology 63(Suppl. 1): keae163295. -
2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2990776Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trialsPUB | DOI | WoS
Rudwaleit M, Brown MA, van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, White K, et al. (2024)
Rheumatology 63(Suppl. 1): keae163202. -
2024 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2989903Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP statusPUB | DOI | WoS | PubMed | Europe PMC
Rudwaleit M, Deodhar A, Bauer L, Gensler L, Hoepken B, Kumke T, Auteri SE, Kim M, Maksymowych W (2024)
RMD Open 10(2): e003884. -
2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2988661HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritisPUB | DOI | WoS | PubMed | Europe PMC
Braun J, Märker-Hermann E, Rudwaleit M, Sieper J (2024)
Annals of the Rheumatic Diseases. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993463Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 StudiesPUB | DOI | WoS
Mease PJ, Dougados M, Dubreuil M, Magrey MN, Marzo-Ortega H, Rudwaleit M, de la Loge C, Fleurinck C, Massow U, Taieb V, Deodhar A (2023)
In: Abstract Supplement ACR Convergence 2023. Arthritis & Rheumatology, 75(Suppl. 9). Hoboken: Wiley: 996-1000. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993460Low Uveitis Rates in Patients with Axial Spondyloarthritis Treated with Bimekizumab: Pooled Results from Phase 2b/3 TrialsPUB | DOI | WoS
Rudwaleit M, Brown MA, Van Gaalen F, Haroon N, Gensler L, Fleurinck C, Marten A, Massow U, De Peyrecave N, Vaux T, White K, et al. (2023)
In: Abstract Supplement ACR Convergence 2023. Arthritis & Rheumatology, 75(Suppl. 9). Hoboken: Wiley: 5060-5062. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993457Work Productivity Improved in Patients with Axial Spondyloarthritis Receiving Bimekizumab Treatment over 52 Weeks: Results from Two Phase 3 StudiesPUB | DOI | WoS
Rudwaleit M, Navarro-Compán V, Deodhar A, Dubreuil M, Morup MF, Taieb V, de la Loge C, Fleurinck C, Massow U, Vaux T, Boonen A (2023)
In: Abstract Supplement ACR Convergence 2023. Arthritis & Rheumatology, 75(Suppl. 9). Hoboken: Wiley: 1020-1023. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993453Factors Associated with Achieving Remission in Patients with Early Peripheral Spondyloarthritis: 10-Year Results from the German Spondyloarthritis Inception CohortPUB | DOI | WoS
Torgutalp M, Peng X, Proft F, Rodriguez VR, Rademacher J, Protopopov M, Haibel H, Rudwaleit M, Sieper J, Poddubnyy D (2023)
In: ACR Convergence 2023 Abstract Supplement. Arthritis & Rheumatology , 75(Suppl. 9). Hoboken: Wiley: 4380-4381. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2993450Sustainability of Clinical Response at Week 52 to Upadacitinib Among Patients with Axial SpA: Data from the SELECT-AXIS 1 and SELECT-AXIS 2 TrialsPUB | DOI | WoS
Navarro-Compán V, Gensler L, Rudwaleit M, Ganz F, Chen S, Stigler J, Schmagel A, Baraliakos X (2023)
In: ACR Convergence 2023 Abstract Supplement. Arthritis & Rheumatology , 75(Suppl. 9). Hoboken: Wiley: 2739-2741. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987166An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial SpondyloarthritisPUB | DOI | WoS
Rudwaleit M, Van den Bosch F, Marzo-Ortega H, Navarro-Compán V, Tham R, Kumke T, Bauer L, Kim M, Gensler LS (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 624-625. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987167Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trialsPUB | DOI | WoS
Rudwaleit M, Brown M, Van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, De Peyrecave N, Vaux T, White K, et al. (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 614-615. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987168Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2PUB | DOI | WoS
Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, De Peyrecave N, Vaux T, Marzo-Ortega H, Navarro-Compán V (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 875-876. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982790
Long-term clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis stratified by baseline MRI and c-reactive protein statusPUB | PDF | DOI | WoS
Zochling J, Robinson PC, Maksymowych WP, Gensler LS, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2023)
Internal Medicine Journal 53(Suppl. 1): 25. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2988304
Case report: Cerebral amyloid angiopathy-related inflammation in a patient with granulomatosis with polyangiitisPUB | PDF | DOI
Seifert RM, Rauch M, Klingebiel R, Boese L-M, Greeve I, Rudwaleit M, Schäbitz W-R (2023)
Frontiers in Neurology 14. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2985913
Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysisPUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
Rudwaleit M, Morup M, Humphries B, Zannat N-E, Willems D, Taieb V, Boonen A (2023)
RMD Open 9(4): e003468. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984077Patient-reported-Outcomes bei Vaskulitispatienten in Deutschland – Daten aus dem KOBRA-QualitätsprojektPUB | DOI | WoS | PubMed | Europe PMC
Löffler C, Rudwaleit M, Lakomek H-J, Stammann C, Hellmich B (2023)
Zeitschrift für Rheumatologie. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987165COMPARISON OF ESTABLISHED AND NEW, PRELIMINARY PROPOSED ASAS CUT-OFFS FOR INFLAMMATORY MRI LESIONS IN THE SACROILIAC JOINTS OF AXIAL SPONDYLOARTHRITIS PATIENTS AND IMPLICATIONS FOR RECRUITMENT IN CLINICAL STUDIESPUB | DOI | WoS
Baraliakos X, Machado P, Bauer L, Hoepken B, Kim M, Kumke T, Tham R, Rudwaleit M (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 621-622. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987161FACTORS ASSOCIATED WITH ACHIEVING REMISSION IN PATIENTS WITH EARLY PERIPHERAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORT (GESPIC)PUB | DOI | WoS
Torgutalp M, Peng X, Proft F, Rodriguez VR, Rademacher J, Protopopov M, Haibel H, Rudwaleit M, Sieper J, Poddubnyy D (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 37-38. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987156QUALITY STANDARDS FOR PATIENTS WITH AXSPA - STATUS QUO OF DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF AXSPA PATIENTS IN GERMANYPUB | DOI | WoS
Schmidt JF, Kiltz U, Stammann C, Schubert-Haack J, Strunk J, Lakomek HJ, Braun J, Rudwaleit M (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 1713. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2980346Changes in diagnosing giant cell arteritis of the temporal artery over a 7.7 year periodPUB | DOI | WoS
Röchter M, Thiesbrummel S, Marchi H, Fuchs C, Rudwaleit M (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 1579. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987172IMPLEMENTATION OF QUALITY STANDARDS FOR HEALTH CARE OF PATIENTS WITH RHEUMATOID ARTHRITIS: FIRST RESULTS FROM THE NATIONAL DATABASE OF THE GERMAN COLLABORATIVE ARTHRITIS CENTRESPUB | DOI | WoS
Albrecht K, Thiele K, Aringer M, Callhoff J, Karberg K, Krueger K, Lakomek J, Lorenz HM, Rudwaleit M, Schmale-Grede R, Schneider M, et al. (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 868-869. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987170ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMABPUB | DOI | WoS
Magrey M, Deodhar A, Mease PJ, Navarro-Compán V, Ramiro S, Rudwaleit M, De la Loge C, Fleurinck C, Taieb V, Morup M, Oortgiesen M, et al. (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 1721. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987174ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITISPUB | DOI | WoS
Navarro-Compán V, Benavent D, Capelusnik D, Van der Heijde D, Landewé RBM, Poddubnyy D, Van Tubergen A, Baraliakos X, Van den Bosch F, Van Gaalen FA, Gensler LS, et al. (2023)
Annals of the Rheumatic Diseases 82(Suppl. 1): 35-36. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2986690Challenges in the diagnosis of axial spondyloarthritisPUB | DOI | WoS | PubMed | Europe PMC
van Gaalen FA, Rudwaleit M (2023)
Best Practice & Research Clinical Rheumatology 37(3): 101871. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2985592Zur Rolle von HLA-B27 in der Pathogenese und Diagnostik der axialen Spondyloarthritis. 50 Jahre nach Entdeckung der starken genetischen AssoziationPUB | DOI | WoS | PubMed | Europe PMC
Braun J, Rudwaleit M, Sieper J (2023)
Zeitschrift fur Rheumatologie. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2983818Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the phase 3 studies BE MOBILE 1 and BE MOBILE 2PUB | DOI | WoS
Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, de Peyrecave N, Vaux T, Giger S, Marzo OH, et al. (2023)
In: Abstracts of the Annual meeting of theSwiss Society of Rheumatology. Swiss Medical Weekly, 153(Suppl. 271). Basel: EMH Schweizerischer Ärzteverlag: 23S. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2984578Achievement of low disease activity over 52 weeks in patients with active axial spondyloarthritis on bimekizumab treatment: Results from the Phase 3 studies BE MOBILE 1 and BE MOBILE 2PUB | DOI | WoS
Baraliakos X, Ramiro S, Magrey M, Rudwaleit M, Haroon N, Fleurinck C, Massow U, de Peyrecave N, Vaux T, Sarno A, Marzo-Ortega H, et al. (2023)
In: Abstract Supplement - 39th Scandinavian Congress of Rheumatology. Scandinavian Journal of Rheumatology , 52(Suppl. 131). Abingdon: Taylor & Francis : 73-74. -
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2982993Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritisPUB | DOI | PubMed | Europe PMC
Rudwaleit M, Machado PM, Taieb V, de Peyrecave N, Hoepken B, Gensler LS (2023)
Therapeutic Advances in Musculoskeletal Disease 15. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982783Systematic Literature Review and Meta-Analysis of Work Productivity in Patients with Axial Spondyloarthritis Treated with Biologic or Targeted Synthetic Disease-Modifying Antirheumatic DrugsPUB | DOI | WoS
Rudwaleit M, Morup M, Humphries B, Zannat NE, Willems D, Taieb V, Boonen A (2023)
Value in Health 26(6 Suppl.): S397. -
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2982796Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 StudiesPUB | WoS
Bird P, Mease PJ, Deodhar A, Dougados M, Dubreuil M, Magrey M, Marzo-Ortega H, Rudwaleit M, de la Loge C, Ellis A, Fleurinck C, et al. (2023)
Internal Medicine Journal 53(S2): 24-25. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968910Nachruf der Deutschen Gesellschaft für Rheumatologie (DGRh) auf den Träger der Kussmaul-Medaille der DGRh Prof. Dr. Ernst FeldtkellerPUB | DOI | WoS | PubMed | Europe PMC
Braun J, Rudwaleit M, Sieper J, Specker C (2023)
Zeitschrift für Rheumatologie. -
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968373 PUB | DOI | WoS | PubMed | Europe PMC
-
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2968388
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trialsPUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
van der Heijde D, Deodhar A, Baraliakos X, Brown MA, Dobashi H, Dougados M, Elewaut D, Ellis AM, Fleurinck C, Gaffney K, Gensler LS, et al. (2023)
Annals of the Rheumatic Diseases. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2969537Association of Clinical Response Criteria and Disease Activity Levels With Physical Function and HRQoL in Patients With Active Axial Spondyloarthritis: 16-Week Results From Two Phase 3 Randomised, Placebo-Controlled StudiesPUB | DOI | WoS
Magrey M, Deodhar A, Mease PJ, Navarro-Compan V, Ramiro S, Rudwaleit M, de la Loge C, Fleurinck C, Taieb V, Morup MF, Oortgiesen M, et al. (2022)
In: ISPOR Europe 2022 Abstracts. Value in Health, 25(12, Suppl.). New York: Elsevier : S427-S428. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968210Treatment with Non-steroidal Anti-inflammatory Drugs Is Associated with Retardation of Radiographic Spinal Progression in Patients with Axial Spondyloarthritis: 10-year Results from the GErman SPondyloarthritis Inception CohortPUB | DOI | WoS
Torgutalp M, Rios-Rodriguez V, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 2946-2948. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968211Comparison of Established and New, Preliminarily Proposed ASAS Cut-Offs for Inflammatory MRI Lesions in the Sacroiliac Joints of Axial Spondyloarthritis Patients and Implications for Recruitment in Clinical StudiesPUB | DOI | WoS
Baraliakos X, Machado P, Bauer L, Hoepken B, Kim M, Kumke T, Tham R, Rudwaleit M (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1997-2000. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968213Uveitis in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: Baseline Characteristics and Incidence Rates During Secukinumab and Placebo Comparative Phase: A Post Hoc AnalysisPUB | DOI | WoS
Brandt-Juergens J, Rudwaleit M, Behrens F, Ritchlin C, Peterlik D, Quebe-Fehling E, Calheiros R, Deodhar A (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 2074-2076. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968219Bimekizumab Improves Signs and Symptoms, Including Inflammation, in Patients with Active Non-Radiographic Axial Spondyloarthritis: 24-Week Efficacy & Safety from a Phase 3, Multicenter, Randomized, Placebo Controlled StudyPUB | DOI | WoS
Deodhar A, van der Heijde D, Gensler L, Xu H, Gaffney K, Dobashi H, Maksymowych WP, Rudwaleit M, Magrey M, Elewaut D, Oortgiesen M, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1101-1105. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968220ASAS Recommendations for Requesting and Reporting Imaging in Patients with Suspected Axial SpondyloarthritisPUB | DOI | WoS
Diekhoff T, Eshed I, Giraudo C, Haibel H, Hermann K-G, de Hooge M, Jans L, Jurik A, Lambert RG, Machado P, Maksymowych WP, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Reumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 788-790. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968222ASAS-EULAR Recommendations for the Management of Axial Spondyloarthritis: 2022 UpdatePUB | DOI | WoS | PubMed | Europe PMC
Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landewe R, Van den Bosch F, Boteva B, Bremander A, Carron P, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022 ,November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1094-1097. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968218Bimekizumab Improves Key Patient Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain and Fatigue: Results from Two Phase 3 StudiesPUB | DOI | WoS
Mease PJ, Deodhar A, Dougados M, Dubreuil M, Magrey M, Marzo-Ortega H, Rudwaleit M, De la Loge C, Ellis A, Fleurinck C, Oortgiesen M, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatolgy (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 810-813. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968217MRI Spinal Lesions in Patients Without MRI or Radiographic Lesions in the Sacroiliac Joints Typical of Axial SpondyloarthritisPUB | DOI | WoS
Maksymowych WP, Ostergaard M, Baraliakos X, Machado P, Pedersen SJ, Weber U, Eshed I, de Hooge M, Sieper J, Poddubnyy D, Rudwaleit M, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 4490-4492. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968216Achieving Increasingly Stringent Clinical Response Criteria & Lower Levels of Disease Activity Is Associated with Greater Improvements in Physical Function & HRQoL in Patients with Active Axial Spondyloarthritis: 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled StudiesPUB | DOI | WoS
Magrey M, Deodhar A, Mease PJ, Navarro-Compan V, Ramiro S, Rudwaleit M, De la Loge C, Fleurinck C, Taieb V, Morup MF, Oortgiesen M, et al. (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 814-816. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968215An Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial SpondyloarthritisPUB | DOI | WoS
Rudwaleit M, Van den Bosch F, Marzo-Ortega H, Navarro-Compan V, Tham R, Kumke T, Bauer L, Kim M, Gensler L (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 1097-1100. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2968214Long-Term Clinical Outcomes of Certolizumab Pegol Treatment in Patients with Active Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein StatusPUB | DOI | WoS
Robinson PC, Maksymowych WP, Gensler L, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2022)
In: ABSTRACT SUPPLEMENT ACR Convergence 2022, November 10–14, 2022, Philadelphia, PA. American College of Rheumatology (Ed); Arthritis & Rheumatology, 74(Suppl. 9). Hoboken: Wiley: 808-810. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966738MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSIONPUB | DOI | WoS
Navarro-Compan V, Rudwaleit M, De Peyrecave N, Fleurinck C, Oortgiesen M, Taieb V, Baraliakos X (2022)
Annals of the Rheumatic Diseases 81(Suppl. 1): 771-772. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966741TREATMENT WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IS ASSOCIATED WITH RETARDATION OF RADIOGRAPHIC SPINAL PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 10-YEAR RESULTS FROM THE GERMAN SPONDYLOARTHRITIS INCEPTION COHORTPUB | DOI | WoS
Torgutalp M, Rodriguez VR, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
In: Annals of the Rheumatic Diseases., 81(Suppl. 1). London: Bmj Publishing Group: 14-15. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966746LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUSPUB | DOI | WoS
Robinson P, Maksymowych WP, Gensler LS, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, Deodhar A (2022)
In: Annals of the Rheumatic Diseases., 81(Suppl. 1). London: Bmj Publishing Group: 774-775. -
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2966748BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDYPUB | DOI | WoS
Deodhar A, Van der Heijde D, Gensler LS, Xu H, Gaffney K, Dobashi H, Maksymowych WP, Rudwaleit M, Magrey M, Elewaut D, Oortgiesen M, et al. (2022)
In: Annals of the Rheumatic Diseases., 81(Suppl. 1). London: Bmj Publishing Group: 772-773. -
2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2965259Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception CohortPUB | DOI | WoS | PubMed | Europe PMC
Torgutalp M, Rodriguez VR, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
Arthritis & Rheumatology . -
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2963951
Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritisPUB | PDF | DOI | Download (ext.) | WoS | PubMed | Europe PMC
Torgutalp M, Rios Rodriguez V, Dilbaryan A, Proft F, Protopopov M, Verba M, Rademacher J, Haibel H, Sieper J, Rudwaleit M, Poddubnyy D (2022)
Annals of the rheumatic diseases 81(9): 1252-1259. -
2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2964357Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd StudyPUB | DOI | WoS | PubMed | Europe PMC
Robinson PC, Maksymowych WP, Gensler LS, Hall S, Rudwaleit M, Hoepken B, Bauer L, Kumke T, Kim M, de Peyrecave N, Deodhar A (2022)
ACR Open Rheumatology. -
2022 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2963700MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working groupPUB | DOI | WoS | PubMed | Europe PMC
Baraliakos X, Ostergaard M, Lambert RG, Eshed I, Machado PM, Pedersen SJ, Weber U, de Hooge M, Sieper J, Poddubnyy D, Rudwaleit M, et al. (2022)
Annals of the Rheumatic Diseases. -
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2962214Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd studyPUB | DOI | WoS | PubMed | Europe PMC
van der Heijde D, Gensler LS, Maksymowych WP, Landewe R, Rudwaleit M, Bauer L, Kumke T, Kim M, Auteri SE, Hoepken B, Deodhar A (2022)
RMD Open 8(1): e002138. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961894Structural Damage in Axial Spondyloarthritis: Is There a Preferred Way to Assess Progression over Time?PUB | DOI | WoS
Baraliakos X, Rodriguez VR, Torgutalp M, Dilbaryan A, Haibel H, Verba M, Sieper J, Braun J, Rudwaleit M, Poddubnyy D (2021)
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 319-321. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961900Data-driven Definitions Based on Inflammatory Lesions for a Positive MRI of the Spine Consistent with Axial SpondyloarthritisPUB | DOI | WoS
Maksymowych W, Lambert R, Baraliakos X, Pedersen S, Eshed I, Weber U, Machado P, De Hooge M, Sieper J, Wichuk S, Poddubnyy D, et al. (2021)
In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73(S9). Hoboken: Wiley: 1878-1880. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961899Scoring MRI Structural Lesions in Sacroiliac Joints of Patients with Axial Spondyloarthritis: How Many Slices Are Optimal?PUB | DOI | WoS
Maksymowych W, Weber U, Baraliakos X, Machado P, Pedersen S, Sieper J, Wichuk S, Poddubnyy D, Rudwaleit M, van der Heijde D, Landewe R, et al. (2021)
In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73(S9). Hoboken: Wiley: 1876-1878. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961897Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Active Non-Radiographic Axial Spondyloarthritis: 3-Year Results from a Phase 3 Multicenter StudyPUB | DOI | WoS
van der Heijde D, Gensler L, Maksymowych W, Landewe R, Rudwaleit M, Bauer L, Hoepken B, Kumke T, Kim M, Deodhar A (2021)
In: Abstract Supplement ACR Convergence 2021. American College of Rheumatology (Ed); Arthritis & Rheumatology, 73(S9). Hoboken: Wiley: 1896-1899. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961896Predictors of 1-Year Treatment Response Among Upadacitinib-Treated Patients with Ankylosing Spondylitis: A Post Hoc AnalysisPUB | DOI | WoS
Magrey M, Ramiro SA, Pinheiro MM, Gao T, Ganz F, Song I-H, Biljan A, Haroon N, Rudwaleit M (2021)
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 1931-1933. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961895Achievement of Stringent Thresholds of Disease Control Is Associated with Reduced Burden on Work and Household Productivity in Patients with Axial SpondyloarthritisPUB | DOI | WoS
Rudwaleit M, Machado P, Gensler L, Taieb V, de Peyrecave N, Hoepken B, van der Heijde D (2021)
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 734-738. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961892Tumor Necrosis Factor Inhibitors Show a Delayed Effect on Radiographic Sacroiliitis Progression in Patients with Early Axial Spondyloarthritis: 10-Year Results from the German Spondyloarthritis Inception CohortPUB | DOI | WoS
Torgutalp M, Rodriguez VR, Verba M, Protopopov M, Proft F, Rademacher J, Haibel H, Rudwaleit M, Sieper J, Poddubnyy D (2021)
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 931-933. -
2021 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2961881Association of the improvement of Synovitis and Enthesitis with quality of life/patient reported outcomes in patients with PsA treated with IxekizumabPUB | DOI | WoS
Kristensen LE, McGonagle D, Rudwaleit M, Kameda H, Holzkaemper T, El Baou C, Smolen J (2021)
In: Abstract Supplement ACR Convergence 2021 . American College of Rheumatology (Ed); Arthritis & Rheumatology , 73(S9). Hoboken: Wiley: 3722-3724. -
2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2959486Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegolPUB | DOI | WoS | PubMed | Europe PMC
Maksymowych WP, Kumke T, Auteri SE, Hoepken B, Bauer L, Rudwaleit M (2021)
Arthritis Research and Therapy 23(1): 274. -
2021 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2958359Entwicklung von Qualitätsstandards für die Versorgung von Patient*innen mit rheumatoider Arthritis zur Anwendung in DeutschlandPUB | DOI | WoS | PubMed | Europe PMC
Kiltz U, Buschhorn-Milberger V, Albrecht K, Lakomek H-J, Lorenz H-M, Rudwaleit M, Schneider M, Schulze-Koops H, Aringer M, Hasenbring MI, Herzer P, et al. (2021)
Zeitschrift fur Rheumatologie.